Cefodox is a 3rd generation semisynthetic cephalosporin antibiotic for oral administration exerting bactericide action on a wide range of gram-positive and gram-negative microorganisms.

Pharmaceutical form: film-coated tablets, Cefpodoxime proxetil 100 mg (200 mg), 10 tablets per pack; lemon-flavored suspension 50 ml, Cefpodoxime proxetil 50 mg (100 mg)/5 ml.

Therapeutic indications: - Upper respiratory tract infections (pharyngitis, tonsilities, sinusitis & otitis media);
- Lower respiratory tract infections (acute and chronic bronchitis, pneumonia);
- Urinary tract infections (acute and chronic pyelonephritis, cystitis, urethritis, asymptomatic bacteriuria, acute uncomplicated urethral, cervical & anorectal gonorrhea);
- Skin and soft tissue infections.

Registration certificates: № UA/4152/02/01, № UA/4152/02/02, № UA/4152/01/02, № UA/4152/01/01.